Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-145721
Filing Date
2025-06-24
Accepted
2025-06-24 16:05:31
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d10137d424b3.htm 424B3 133205
2 GRAPHIC g10137g13u34.jpg GRAPHIC 47918
  Complete submission text file 0001193125-25-145721.txt   200408
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-287949 | Film No.: 251068989
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)